Pegavision Corp
TWSE:6491
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (4.3), the stock would be worth NT$383.86 (36% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.1 | NT$281.5 |
0%
|
| 3-Year Average | 4.3 | NT$383.86 |
+36%
|
| 5-Year Average | 4.6 | NT$419.42 |
+49%
|
| Industry Average | 2.8 | NT$250.81 |
-11%
|
| Country Average | 1.8 | NT$162.03 |
-42%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
NT$21.9B
|
/ |
Jan 2026
NT$7B
|
= |
|
|
NT$21.9B
|
/ |
Dec 2026
NT$8.1B
|
= |
|
|
NT$21.9B
|
/ |
Dec 2027
NT$8.6B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| TW |
P
|
Pegavision Corp
TWSE:6491
|
22B TWD | 3.1 | 13.5 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 10.7 | 39.3 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
57B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.2B CHF | 3.4 | 35.6 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
89.7B DKK | 3.2 | 22.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 3.2 | 31 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.1B GBP | 2.2 | 31.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
38B CNY | 8.4 | 23 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
875B JPY | 6.7 | 49.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | 99.2 | -37.9 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 1.1 | -15 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 1.1 |
| Median | 1.8 |
| 70th Percentile | 3.1 |
| Max | 384 578.4 |
Other Multiples
Pegavision Corp
Glance View
Pegavision Corp. focusing on research, development, manufacture and marketing of soft contact lenses and the medical optic devices. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2014-12-30. The firm distributes its products within domestic market and to overseas markets.
